{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:47:36Z","timestamp":1761058056158},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1378\/chest.126.3.679","type":"journal-article","created":{"date-parts":[[2004,9,13]],"date-time":"2004-09-13T13:53:00Z","timestamp":1095083580000},"page":"679-686","source":"Crossref","is-referenced-by-count":12,"title":["Cardiac Sympathetic Nerve Activity Can Detect Congestive Heart Failure Sensitively in Patients With Hypertrophic Cardiomyopathy"],"prefix":"10.1016","volume":"126","author":[{"given":"Go","family":"Hiasa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mareomi","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideyuki","family":"Saeki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiyoshi","family":"Ogimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Ohtsuka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuji","family":"Shigematsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1378\/chest.126.3.679_bib1","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/0002-9149(81)90535-X","article-title":"Prognosis of hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamics feature","volume":"47","author":"McKenna","year":"1981","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.126.3.679_bib2","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0002-9149(87)90998-2","article-title":"Occurrence and significance of progressive left ventricular wall thinning and relative cavity dilatation in hypertrophic cardiomyopathy","volume":"59","author":"Spirito","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.126.3.679_bib3","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/0002-8703(79)90012-7","article-title":"Progression to left ventricular dilatation in patients with hypertrophic obstructive cardiomyopathy","volume":"97","author":"Ten Cate","year":"1979","journal-title":"Am Heart J"},{"key":"10.1378\/chest.126.3.679_bib4","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/0002-8703(85)90358-8","article-title":"Thallium perfusion and cardiac enzyme abnormalities in patients with familial hypertrophic cardiomyopathy","volume":"9","author":"Nagata","year":"1985","journal-title":"Am Heart J"},{"key":"10.1378\/chest.126.3.679_bib5","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1253\/jcj.54.354","article-title":"Persistent elevation of cardiac enzymes in a patient with hypertrophic cardiomyopathy\u2014with special reference to electrocardiographic, echocardiographic and 201-thallium myocardial scintigraphic findings","volume":"54","author":"Hamada","year":"1990","journal-title":"Jpn Circ J"},{"issue":"suppl","key":"10.1378\/chest.126.3.679_bib6","first-page":"I462","article-title":"Transition from typical hypertrophic cardiomyopathy to end-stage congestive heart failure: 12-year follow-up study in 210 patients","volume":"96","author":"Hamada","year":"1997","journal-title":"Circulation"},{"key":"10.1378\/chest.126.3.679_bib7","first-page":"471","article-title":"Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure","volume":"33","author":"Merlet","year":"1992","journal-title":"J Nucl Med"},{"key":"10.1378\/chest.126.3.679_bib8","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/0735-1097(95)00374-6","article-title":"Iodine-123 metaiodobenzylguanidine images reflect intense myocardial adrenergic nervous activity in congestive heart failure independent of underlying cause","volume":"26","author":"Imamura","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.126.3.679_bib9","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S1071-3581(98)90112-X","article-title":"Cardiac death prediction and impaired cardiac sympathetic innervation assessed by MIBG in patients with failing and nonfailing heart","volume":"5","author":"Nakata","year":"1998","journal-title":"J Nucl Cardiol"},{"key":"10.1378\/chest.126.3.679_bib10","first-page":"1486","article-title":"Direct evidence of impaired cardiac sympathetic innervation in essential hypertensive patients with left ventricular hypertrophy","volume":"39","author":"Kuwahara","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1378\/chest.126.3.679_bib11","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0002-8703(05)80183-8","article-title":"Quantitative analysis of123I-metaiodobenzylguanidine (MIBG) uptake in hypertrophic cardiomyopathy","volume":"119","author":"Nakajima","year":"1990","journal-title":"Am Heart J"},{"key":"10.1378\/chest.126.3.679_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000470353","article-title":"Different myocardial distribution patterns between iodine-123 metaiodobenzylguanidine and thallium-201 in hypertrophic cardiomyopathy","volume":"6","author":"Fujiwara","year":"1992","journal-title":"Am J Noninvasive Cardiol"},{"key":"10.1378\/chest.126.3.679_bib13","first-page":"197","article-title":"Disease stage classification in hypertrophic cardiomyopathy by dual analysis of iodine-123-labeled metaiodobenzylguanidine and thallium-201 myocardial scintigraphy","volume":"31","author":"Hiasa","year":"2001","journal-title":"Jpn J Appl Physiol"},{"key":"10.1378\/chest.126.3.679_bib14","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.CIR.93.5.841","article-title":"Report of the 1995 World Health Organization\/International Society and Federation of Cardiology task force on the definition and classification of cardiomyopathies","volume":"93","author":"Richardson","year":"1996","journal-title":"Circulation"},{"key":"10.1378\/chest.126.3.679_bib15","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1161\/01.CIR.96.5.1520","article-title":"Class Ia antiarrhythmic drug cibenzoline: a new approach to the medical treatment of hypertrophic obstructive cardiomyopathy","volume":"96","author":"Hamada","year":"1997","journal-title":"Circulation"},{"key":"10.1378\/chest.126.3.679_bib16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0002-8703(49)90562-1","article-title":"The ventricular complex in left ventricular hypertrophy as obtained by unipolar precordial and limb leads","volume":"37","author":"Sokolow","year":"1949","journal-title":"Am Heart J"},{"key":"10.1378\/chest.126.3.679_bib17","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0002-9343(89)80817-4","article-title":"Usefulness of total 12-lead QRS voltage compared with other criteria for determining left ventricular hypertrophy in hypertrophic cardiomyopathy: analysis of 57 patients studied at necropsy","volume":"87","author":"Dollar","year":"1989","journal-title":"Am J Med"},{"key":"10.1378\/chest.126.3.679_bib18","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/01.CIR.58.6.1072","article-title":"Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements","volume":"58","author":"Sahn","year":"1978","journal-title":"Circulation"},{"key":"10.1378\/chest.126.3.679_bib19","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1161\/01.CIR.37.5.759","article-title":"Idiopathic subaortic stenosis: clinical analysis of 126 patients with emphasis on the natural history","volume":"37","author":"Frank","year":"1968","journal-title":"Circulation"},{"key":"10.1378\/chest.126.3.679_bib20","doi-asserted-by":"crossref","first-page":"515","DOI":"10.7326\/0003-4819-77-4-515","article-title":"The clinical course in muscular subaortic stenosis: a retrospective and prospective study of 60 hemodynamically proved cases","volume":"77","author":"Adelman","year":"1972","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.126.3.679_bib21","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/0735-1097(93)90054-5","article-title":"Coexistence of sudden cardiac death and end-stage heart failure in familial hypertrophic cardiomyopathy","volume":"22","author":"Hecht","year":"1993","journal-title":"J Am Coll Cardiol"},{"key":"10.1378\/chest.126.3.679_bib22","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0002-9149(81)90604-4","article-title":"Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study","volume":"48","author":"Maron","year":"1981","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.126.3.679_bib23","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0002-8703(84)90624-0","article-title":"Prognosis in hypertrophic cardiomyopathy","volume":"108","author":"Koga","year":"1984","journal-title":"Am Heart J"},{"key":"10.1378\/chest.126.3.679_bib24","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1161\/01.CIR.86.3.730","article-title":"Prognostic determinants in hypertrophic cardiomyopathy: prospective evaluation of a therapeutic strategy based on clinical, Holter, hemodynamic and electrophysiologic findings","volume":"86","author":"Fananapazir","year":"1992","journal-title":"Circulation"},{"key":"10.1378\/chest.126.3.679_bib25","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/0002-9149(93)91111-T","article-title":"Prognosis in hypertrophic cardiomyopathy observed in a large clinic population","volume":"72","author":"Koffland","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1378\/chest.126.3.679_bib26","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1136\/hrt.44.6.650","article-title":"Assessment of chest pain in hypertrophic cardiomyopathy using exercise thallium-201 myocardial scintigraphy","volume":"44","author":"Pitcher","year":"1980","journal-title":"Br Heart J"},{"key":"10.1378\/chest.126.3.679_bib27","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1161\/01.CIR.76.6.1214","article-title":"Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography","volume":"76","author":"O'Gara","year":"1987","journal-title":"Circulation"},{"key":"10.1378\/chest.126.3.679_bib28","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1161\/01.CIR.83.5.1660","article-title":"Myocardial metabolic, hemodynamic, and electrocardiographic significance of reversible thallium-201 abnormalities in hypertrophic cardiomyopathy","volume":"83","author":"Cannon","year":"1991","journal-title":"Circulation"},{"key":"10.1378\/chest.126.3.679_bib29","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1042\/cs0810723","article-title":"Serum creatine kinase MM isoforms in hypertrophic cardiomyopathy","volume":"81","author":"Hamada","year":"1991","journal-title":"Clin Sci (Lond)"},{"key":"10.1378\/chest.126.3.679_bib30","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/0735-1097(89)90391-4","article-title":"Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123-metaiodobenzylguanidine","volume":"14","author":"Stanton","year":"1998","journal-title":"J Am Coll Cardiol"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215312058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215312058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,3]],"date-time":"2019-02-03T19:54:33Z","timestamp":1549223673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215312058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S0012369215312058"],"URL":"https:\/\/doi.org\/10.1378\/chest.126.3.679","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}